Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely developed TPD approaches. With this assessment, we target each preclinical experiments and clinical trials to offer an extensive summary of the protection and scientific efficiency of PROTACs and MGDs in hematologic malignancies over the past twenty years. https://at-5633210.blogocial.com/the-best-side-of-squalene-67679712